Should You Prescribe a Muscle Relaxant for Initial Lower Back Pain?
Yes, muscle relaxants are an appropriate option for initial acute low back pain when NSAIDs or acetaminophen alone provide insufficient relief, but they should be prescribed for short-term use only (5-7 days maximum) due to significant sedation risk. 1, 2
First-Line Approach: Start Without Muscle Relaxants
Begin with NSAIDs (e.g., ibuprofen 400-800 mg three times daily or naproxen 500 mg twice daily) as your first-line pharmacologic choice, as they provide approximately 10 points greater pain relief on a 100-point scale compared to acetaminophen and have the strongest evidence for acute low back pain. 1, 2
Acetaminophen (up to 4 g daily) is an acceptable alternative if NSAIDs are contraindicated due to cardiovascular disease, gastrointestinal bleeding risk, or renal insufficiency, though it is slightly less effective. 1, 2
Combine medication with non-pharmacologic measures: advise the patient to remain active within pain tolerance (bed rest worsens outcomes), apply superficial heat with heating pads, and provide reassurance that 90% of acute episodes resolve within 4-6 weeks. 1, 2
When to Add a Muscle Relaxant
Add a non-benzodiazepine muscle relaxant only if NSAID or acetaminophen monotherapy provides inadequate relief after 2-3 days. 1, 2, 3
Specific Prescribing Instructions
Prescribe cyclobenzaprine, methocarbamol, or tizanidine (avoid benzodiazepines like diazepam due to higher abuse potential and mortality risk when combined with other medications). 1, 3
Duration: 5-7 days maximum, not to exceed 14 days—muscle relaxants have evidence only for short-term relief and are associated with central nervous system adverse effects, primarily sedation occurring in approximately 49% of patients. 1, 2, 3
Dosing frequency: typically three times daily (e.g., cyclobenzaprine 5-10 mg three times daily, methocarbamol 500-750 mg three times daily). 2, 3
Warn patients explicitly about sedation and drowsiness—advise against driving or operating machinery until they know how the medication affects them. 3
Critical Safety Considerations
Never combine muscle relaxants with opioids—this combination increases mortality risk 3- to 10-fold due to potentiated respiratory depression and carries an FDA black box warning. 3
Assess cardiovascular and gastrointestinal risk factors before prescribing NSAIDs—use the lowest effective dose for the shortest duration, and consider adding a proton pump inhibitor in patients with peptic ulcer disease history or age >65 years. 1, 2
Avoid systemic corticosteroids entirely—they have been proven ineffective for low back pain with good-quality evidence showing no benefit over placebo. 1, 2
What NOT to Do
Do not prescribe opioids for initial management—reserve them only for severe, disabling pain unresponsive to all other measures, and even then use time-limited courses with careful monitoring due to abuse potential and lack of superior efficacy. 1, 2
Do not prescribe muscle relaxants for chronic low back pain (>12 weeks)—evidence supports their use only in acute pain settings. 3, 4
Do not order imaging (X-ray, MRI, CT) in the initial evaluation unless red flags are present (cauda equina symptoms, fever, unexplained weight loss, history of cancer, significant trauma, progressive neurologic deficits)—early imaging increases unnecessary procedures without improving outcomes. 1, 2
Follow-Up and Reassessment
Reevaluate at 1 month if symptoms persist without improvement—consider earlier reassessment (2 weeks) in patients over 65 years, those with radicular symptoms, or worsening pain. 2
If pain persists beyond 4-6 weeks despite conservative therapy, obtain plain radiography (not MRI initially) and refer to physical therapy for structured exercise programs. 1, 2